Procedural ultrasound for surgeons: (CONSULTANT-LEVEL EXAMINATION)

Published on 22/03/2015 by admin

Filed under Critical Care Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1495 times

44

Procedural ultrasound for surgeons

(CONSULTANT-LEVEL EXAMINATION)

Ultrasound (US) has become an indispensable part of the surgeon’s armamentarium, useful in both bedside assessment and operative treatment. Because the diagnostic and critical care applications of US are discussed elsewhere, this chapter will focus on intraoperative and US-guided surgical procedures.

Intraoperative ultrasonography

Intraoperative ultrasonography (IOUS) has been described extensively since the 1980s, and although its main applications are in hepatobiliary and pancreatic surgery, it also has roles in neurosurgery, cardiovascular, and endocrine surgery. In oncologic surgery, IOUS allows identification of lesions not detectable with preoperative imaging modalities and accurate assessment of tumor extension and relationship to critical blood vessels to determine resectability and guide operative planning. By providing real-time data, it enables safe, expeditious, and thorough operative procedures. IOUS helps define the characteristics and location of nonpalpable lesions or structures, such as parenchymal masses (cysts, hemangiomas, and tumors), biliary calculi, dilatated ducts, and space-filling structures in the retroperitoneum, such as pseudocysts and abscesses. IOUS-guided procedures may include biopsy and aspiration, cannulation of structures, and placement of probes for radiofrequency, microwave, and cryotherapeutic ablative technologies. When compared with contrast radiography, IOUS is safer in that it does not expose the patient to ionizing radiation, contrast agents, or complications from cannulation.

Liver

IOUS helps to evaluate undifferentiated hepatic masses for malignancy and resectability. It is frequently used to screen for unsuspected liver metastases in colorectal operations and occult lesions in planned hepatobiliary resections. It reveals deep hepatic sectoral anatomy and, as such, is commonly used to guide parenchymal resections and biopsies and to target intrahepatic lesions during ablation procedures.

Primary hepatocellular carcinoma usually occurs in the setting of dense cirrhosis, which makes visualization and palpation difficult. Furthermore, many hepatomas are smaller than 5 cm and are not fully evident by exploration and palpation alone. IOUS aids with anatomic localization, definition of satellite lesions, and imaging of segmental/subsegmental vascular invasion of the portal or hepatic veins (Figure 44-1).

The same principles apply to hepatic metastases of all tissue types. IOUS has higher (>90%) sensitivity and specificity than preoperative computed tomography (CT), US, or surgical inspection in screening for these lesions, largely because IOUS detects tumors less than 1 cm.1 When performed as a routine screening procedure during colorectal resections, occult metastases are identified nearly 10% of the time. Likewise, in determining resectability of other intra-abdominal malignancies (pancreas, gallbladder, stomach), identification of occult metastases in the liver dramatically changes the surgical approach from curative to palliative intent. The results of many studies show that IOUS changes the clinical management in up to 50% of patients undergoing hepatic resection for malignancy. Even when intraoperative US does not change surgical management, it results in corrected staging and, consequently, alters postoperative treatment in 11% of patients.2,3

Bloed et al4 showed that despite preoperative triphasic CT, intraoperative US still provided additional useful information in 50% of their patients, which resulted in a change in the surgical procedure in 15%. In a study done at Royal Prince Alfred Hospital, 20 of 30 hepatic resections (67%) were changed or guided by IOUS. IOUS detected 26 more metastases (44%) in 10 of 19 patients (1-5 per patient). Two patients had preoperatively suspected metastases refuted by IOUS-guided biopsy. Eight of the 11 patients (73%) undergoing resection of primary carcinoma of the liver had the planned procedure changed or guided by IOUS.5

Gall bladder

IOUS has equivalent efficacy while providing cost and time savings when compared with cholangiography in biliary disease and has great utility in identifying common bile duct (CBD) pathology during open operations, especially because these procedures typically occur amidst inflammation, malignancy, or prior surgery. In cases of unresectable disease, biopsy can be guided by IOUS, and during reconstructive procedures, transhepatic biliary stent placement can be facilitated.

In a recent study, IOUS identified significant biliary abnormalities in 20 patients (40%) undergoing cholecystectomy, including a foreshortened cystic duct (<1 cm) in 7 patients (14%), CBD stones in 4 patients (8%), abnormal cystic duct anatomy in 4 patients (8%), and abnormal vascular anatomy in 8 patients (16%).6

Kidney

The relationship of renal tumor to structures deeper within the sinus may be more readily appreciated using IOUS. In a series of patients with hereditary renal carcinoma, IOUS identified tumors that were undetectable by the surgeon in 25% of cases, some as large as 4 cm, of which 50% were pathologically proven renal cell carcinoma (Figure 44 E-1).

Intraoperative real-time renal scanning also displays a cross section of renal tissue and allows accurate, three-dimensional stone localization. This is of value when performing open stone surgery. After mobilizing the kidney, it is scanned in multiple planes until the stone is identified by its characteristic dense echo pattern and the presence of acoustic shadowing. Fine-needle probes are then passed to the stone and a nephrotomy made directly over the stone. With this technique, an experienced ultrasonographer can identify stones 2 mm or more in diameter.

Pancreas

IOUS techniques are particularly useful in the pancreas because of its retroperitoneal location. It augments the staging of pancreatic malignancies, especially neuroendocrine tumors. Perhaps one of the best-defined applications for IOUS is for localization of pancreatic islet cell tumors, both functional and nonfunctional. These tumors are characteristically small (<5 mm) and hypoechoic on US, but more important, preoperative and even intraoperative identification can be unyielding. Intrapancreatic insulinomas can be detected with IOUS between 85% and 100% of the time, and gastrinomas are identified with a 95% frequency, although these rates correlate directly with IOUS experience.7 In parenchymal-sparing enucleation procedures for tumors or cysts, IOUS helps reveal the relationship of the lesion to the main pancreatic duct in order to protect against the development of a significant pancreatic fistula.

IOUS may be used for pancreatic pseudocyst drainage procedures and can help determine whether multiple pseudocysts are connected, or not, and assess the adequacy of drainage (Figure 44-2). Complications of chronic pancreatitis, such as pseudocysts, dilatated and strictured pancreatic ducts, and portal/splenic venous hypertension, may require surgical intervention but can be difficult to understand anatomically by using visible and tactile exploration alone. IOUS is also excellent for determining the size and characteristics of an obstructed pancreatic duct, an important consideration in choosing a ductal drainage procedure over resection in some cases of chronic pancreatitis. Intraductal papillary projections can occasionally be seen by using IOUS in cases of intraductal papillary mucinous neoplasms, although this is usually unnecessary if the preoperative endoscopic and imaging evaluation was adequate.

Pancreatic adenocarcinoma is an aggressive malignancy that is often unresectable because of local invasion and/or regional metastases. IOUS can help the surgeon determine resectability and whether complex reconstructive maneuvers, such as portal vein reconstruction, will be necessary.

Ultrasound-guided percutaneous surgical procedures

Ultrasound is also used to facilitate many minor surgical procedures done outside the operating room; several of the most common procedures are discussed below.

Suprapubic catheter insertion

Suprapubic catheter insertion (SPC) is indicated in patients with urinary retention after trauma or permanent bladder dysfunction from neurologic conditions.

Ultrasound-guided suprapubic catheter (USSPC) insertion is the safest method, especially in patients with previous abdominal or pelvic surgery, because it reduces the incidence of bowel injury observed in blind SPC while avoiding general anesthesia. The goals of USSPC are to evaluate bladder filling, identify interposed bowel, and guide the needle to the appropriate site (Figure 44 E-2). In patients with sufficient bladder distension and intervening bowel excluded, the puncture site is usually 2 to 4 cm above the symphysis pubis. The position should be confirmed using US before and after balloon inflation to avoid accidental insertion of the catheter tip into the urethra or a diverticulum.

Although the literature on USSPC is sparse, the few studies that have been done show reduced complication rates, improved first-time success rates, and subsequent reduction in infections.10 As a result, recent British Association of Urological Surgeons guidelines recommend US guidance for SPC insertion whenever possible.11

Percutaneous cholecystostomy

Percutaneous cholecystostomy (PC) is used as a temporizing measure in critically ill patients with acute cholecystitis who are not candidates for immediate surgical gallbladder removal (Figure 44-3). Once the patient’s condition is stable enough for surgery, definite treatment is still cholecystectomy. One exception is acalculous cholecystitis, where percutaneous drainage may be the only treatment required.

PC is performed via a US-guided transhepatic approach through the right lobe to access the gallbladder. A transhepatic is preferred over a transperitoneal approach because of the risk of bile peritonitis in the latter. Bile samples should be collected for Gram staining and cultures. Before catheter removal, ensure patency of the cystic duct by clamping the tube for 48 hours and evaluate for signs of cystic duct obstruction (i.e., fever, pain, or elevated white blood cell [WBC] count).

Surgical gallbladder removal is the best treatment for both acute calculous and acalculous cholecystitis because of its curative nature and low mortality rate of 0% to 0.8%.12,13 However, the mortality rate in elderly or critically ill patients with comorbid disease skyrockets to 14% to 30%14,15; therefore PC provides a safe alternative in the critically ill and elderly.16,17

Percutaneous abscess drainage

Ultrasound-guided percutaneous abscess drainage (USPAD) is highly effective in treating abdominal and pelvic abscesses, a common surgical problem. It may be used either as a preparatory step or an alternative to open surgery. USPAD offers real-time imaging, reduced radiation, and the option to perform the procedure at the bedside. Multiloculated abscesses should be drained using CT, which may necessitate multiple catheters.

Guidewire selection is extremely important to good outcomes and should be stiff enough to guide dilators and catheters into the abscess but not be so stiff as to prevent easy coiling within the abscess. Once access is gained to the collection, it is critical to maintain guidewire access during the entire length of the drainage procedure. If access is not maintained, reentry may be difficult because of spontaneous decompression of the abscess or difficulties in imaging the disturbed region.

The success of USPAD is well documented and has become the standard of care in treating intraabdominal and pelvic abscesses (Figure 44 E-3).

Breast cyst drainage

Breast cysts are a common problem affecting women of all ages. Although asymptomatic stable cysts do not require treatment, larger cysts may cause pain and benefit from aspiration (Figure 44 E-4). In addition, any cyst with a potential solid component should be evaluated to exclude malignancy. Fine-needle aspiration is done using ultrasound to ensure proper placement within the fluid-filled cavity. The procedure is used to both diagnose and treat the cyst. If the aspirated fluid is clear and the mass resolves, malignancy is unlikely. If the fluid is bloody or if there is a residual mass after aspiration, referral for core-needle or excisional biopsy is indicated.

Postoperative seroma drainage

A seroma is a collection of clear serous fluid that can develop after surgery. Seromas are differentiated from hematomas by a lack of red blood cells and from abscesses by a lack of pus. Seromas commonly develop after mastectomies, facial plastic surgeries, lymph node removal, abdominal surgeries, and, in some cases, brachytherapy. Most seromas will resolve without intervention, but persistent seromas may require percutaneous drainage with US guidance. The technique is similar to cyst aspiration as discussed earlier.

References

1. Callery, MP, Strasberg, SM, Doherty, GM, et al, Staging laparoscopy with laparoscopic ultrasonography: optimizing resectability in hepatobiliary and pancreatic malignancy. J Am Coll Sur. 1997; 185:33–39.

2. Paul, MA, Mulder, LS, Cuesta, MA, et al. Impact of intraoperative ultrasonography on treatment strategy for colorectal cancer. Br J Surg. 1994; 81:1660–1663.

3. Boutkan, H, Luth, W, Meyer, S, Cuesta, M, et al. The impact of intraoperative ultrasonography of the liver on the surgical strategy of patients with gastrointestinal malignancies and hepatic metastases. Eur J Surg Oncol. 1992; 18:342–346.

4. Bloed, W, van Leeuwen, MS, BorelRinkes, IH. Role of intraoperative ultrasound of the liver with improved preoperative hepatic imaging. Eur J Surg. 2000; 166:691–695.

5. Solomon, MJ, Stephen, MS, Gallinger, S, White, GH. Does intraoperative hepatic ultrasonography change surgical decision making during liver resection. Am J Surg. 1994; 168:307–310.

6. Pfluke, JM, Bowers, SP, Jr., Laparoscopic intraoperative biliary ultrasonography: findings during laparoscopic cholecystectomy for acute disease. J Laparoendosc Adv Surg Tech . 2011; 21:505–509.

7. John, TG, Wright, A, Allan, PL, et al. Laparoscopy with laparoscopic ultrasonography in the TNM staging of pancreatic carcinoma. World J Surg. 1999; 23:870–881.

8. Luck, A, Thomas, M, Roediger, WEW, Hewett, PJ. Localization of the nonpalpable colonic lesion with intraoperative ultrasound. Surg Endosc. 1999; 13:526–527.

9. Greif, F, Belenky, A, Aranovich, D, et al, Intraoperative ultrasonography: a tool for localizing small colonic polyps. Int J Colorectal Di. 2005; 20:502–506.

10. Ahluwalia, RS, Johal, N, Kouriefs, C, et al. The surgical risk of suprapubic catheter insertion and long-term sequelae. Ann R Coll Surg Engl. 2006; 88:210–213.

11. Harrison, SC, Lawrence, WT, Morley, R, et al. British Association of Urological Surgeons’ suprapubic catheter practice guidelines. BJU Int. 2011; 107:77–85.

12. Gilliland, TM, Traverso, LW. Modern standards for comparison of cholecystectomy with alternative treatments for symptomatic cholelithiasis with emphasis on long-term relief of symptoms. Surg Gynecol Obstet. 1990; 170:39–44.

13. Pickleman, J, Gonzalez, RP. The improving results of cholecystectomy. Arch Surg. 1986; 121:930–934.

14. Houghton, PW, Jenkinson, LR, Donaldson, LA, Cholecystectomy in the elderly: a prospective study. Br J Surg. 1985;72:220–222.

15. Frazee, RC, Nagorney, DM, Mucha, P, Jr. Acute acalculous cholecystitis. Mayo Clin Proc. 1989; 64:163–167.

16. Radder, RW. Ultrasonically guided percutaneous catheter drainage for gallbladder empyema. Diagn Imaging. 1980; 49:330–333.

17. Bakkaloglu, H, Yanar, H, Guloglu, R, et al. Ultrasound guided percutaneous cholecystostomy in high-risk patients for surgical intervention. World J Gastroenterol. 2006; 12:7179–7182.